ResultsIQ

ResultsIQ › Latest results › Natural Capsules Limited

Natural Capsules Limited Q1 FY27 results press release summary

NSE: NATCAPSUQ · BSE: 524654

Results press release of 13 Aug 2026, summarised by AI from the filing.

Natural Capsules Q1FY27 revenue ₹4871 cr, EBITDA ₹1.12 cr, PAT ₹5.74 cr; HPMC line converted to gelatine.

Key takeaways

  1. Result Q1FY27 revenue ₹4871 cr, EBITDA ₹1.12 cr, EBITDA margin 2.30%, PAT ₹5.74 cr.
  2. Guidance Management confident of sustaining profitability through the remainder of the year and sustained capsules performance through the financial year.
  3. Change One HPMC line temporarily converted to a gelatine line; second line expected to be converted in the coming month.
  4. Driver Sustained demand across capsule products and improvement in realisations, with input cost pass-throughs supporting margins.
  5. Risk US HPMC demand environment erratic with uncertainty around duty structures, and no material US export volumes during the quarter.

Original filing on BSE

Natural Capsules Limited Q1 FY27 results

As filed: Revenue ₹48.7 cr (+8% year on year), EBITDA ₹1.1 cr (+12% year on year), PAT −₹5.7 cr, EBITDA margin 2.3% (+8 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹58.5 cr (+30% year on year), EBITDA ₹1.3 cr (−73% year on year), PAT −₹5.0 cr (−300% year on year), EBITDA margin 2.3% (−884 bps). Score 20 of 100, Below trend. EBITDA margin fell 884 bps year on year. Consolidated profit -598% but standalone +84%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −6.5% in 29 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹34.2 cr, EBITDA ₹1.9 cr, PAT ₹0.4 cr, EBITDA margin 5.5%. Not scored. No result for the same quarter last year. Share price after the results: −10.5% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹45.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.1%. Not scored. No result for the same quarter last year. Share price after the results: −11.6% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹44.0 cr, EBITDA ₹4.0 cr, PAT ₹3.0 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹44.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.4%. Not scored. No result for the same quarter last year. Share price after the results: −2.2% in 29 days (Nifty 500: +3.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Natural Capsules Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.